ストックスクリーナーアプリを入手
192.06
0.30%
-0.613
前日終値:
$192.67
開ける：
$190.61
24時間の取引高:
168.51K
Relative Volume:
0.17
時価総額：
$21.25B
収益：
$11.28B
当期純損益:
$1.07B
株価収益率:
21.19
EPS:
9.0657
ネットキャッシュフロー:
$1.33B
1週間 パフォーマンス:
-2.31%
1か月 パフォーマンス:
-3.00%
6か月 パフォーマンス:
+7.90%
1年 パフォーマンス:
+7.94%
1日の値動き範囲:
$190.41
$193.50
1週間の範囲:
$187.50
$198.78
52週間の値動き範囲:
$164.65
$213.50
Quest Diagnostics Inc Stock (DGX) Company Profile
Compare DGX vs TMO, DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
191.96 | 21.33B | 11.28B | 1.07B | 1.33B | 9.0657 |
TMO
Thermo Fisher Scientific Inc
|
463.29 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.75 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
555.41 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.03 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
NTRA
Natera Inc
|
208.02 | 29.60B | 2.31B | -208.16M | 76.11M | -1.5366 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-08-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 開始されました | Redburn Atlantic | Buy |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-01-06 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | Jefferies | Buy |
| 2024-10-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 再開されました | Evercore ISI | In-line |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-12-12 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-06-29 | 開始されました | Piper Sandler | Neutral |
| 2023-05-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-03 | アップグレード | Citigroup | Sell → Neutral |
| 2023-01-23 | 開始されました | Evercore ISI | In-line |
| 2022-11-17 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-04-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-02-23 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-02 | ダウングレード | Jefferies | Buy → Hold |
| 2022-01-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-05-04 | アップグレード | UBS | Neutral → Buy |
| 2021-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | アップグレード | Argus | Hold → Buy |
| 2020-07-29 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-06-09 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-04-28 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | アップグレード | Citigroup | Neutral → Buy |
| 2020-04-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-12-19 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | ダウングレード | Goldman | Neutral → Sell |
| 2019-04-02 | アップグレード | Jefferies | Hold → Buy |
| 2019-03-18 | 再開されました | Credit Suisse | Neutral |
| 2019-01-31 | ダウングレード | Argus | Buy → Hold |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2019-01-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | ダウングレード | Goldman | Buy → Neutral |
すべてを表示
Quest Diagnostics Inc (DGX) 最新ニュース
Quest Diagnostics Incorporated $DGX Shares Sold by Keybank National Association OH - MarketBeat
DGX SEC FilingsQuest Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Quest Diagnostics Incorporated $DGX Shares Acquired by Davis Selected Advisers - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Holdings Increased by Artemis Investment Management LLP - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Short Interest Update - MarketBeat
[8-K] QUEST DIAGNOSTICS INC Reports Material Event - Stock Titan
Quest Diagnostics Incorporated $DGX Shares Sold by Pictet Asset Management Holding SA - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Sold by Danica Pension Livsforsikringsaktieselskab - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Vanguard reports 8.27M Quest Diagnostics shares (NYSE: DGX) stake - Stock Titan
Quest Diagnostics Inc (DGX) Stock Price & 30 Year Financial Data - GuruFocus
Quest Diagnostics Incorporated $DGX Shares Purchased by UBS Group AG - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Purchased by Vanguard Group Inc. - MarketBeat
Valmont Industries posts upbeat Q1 results, joins UnitedHealth Group, Quest Diagnostics and other big stocks moving higher on Tuesday - MSN
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vanguard reports 6.10M-share stake in Quest Diagnostics (DGX) — 5.54% - Stock Titan
Quest Diagnostics (DGX) sells $500M 5.00% senior notes due 2036 at 98.751% - Stock Titan
Quest Diagnostics Debt Raise And ctDNA Alliance Spark Valuation Questions - Yahoo Finance
JPMorgan Mid Cap Value Fund's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
BlackRock Systematic Multi-Strategy Fund's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
Quest Diagnostics Prices $500 Million of Senior Notes - GuruFocus
Smart Money is Buying Quest Diagnostics Inc. (DGX) - The Acquirer's Multiple
Quest Diagnostics Inc (DGX) Stock Price, Trades & News - GuruFocus
Quest Diagnostics Incorporated (DGX) stock price, news, quote and history - Yahoo Finance Australia
Quest Diagnostics prices $500 million senior notes offering By Investing.com - Investing.com Canada
Quest Diagnostics Inc files for senior notes, size not disclosed - marketscreener.com
Quest Diagnostics (DGX) launches senior note offering; may repay $500M 2026 notes - Stock Titan
Advisors Capital Management LLC Buys 16,194 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Evercore ISI Group Maintains Quest Diagnostics (DGX) In-Line Recommendation - MSN
Quest Diagnostics Incorporated $DGX Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
Quest Diagnostics (DGX) SVP reports 49-share dividend reinvestment - Stock Titan
Quest Diagnostics (NYSE: DGX) director acquires shares through dividend reinvestment - Stock Titan
Dividend plan boosts Quest Diagnostics (NYSE: DGX) director stake - Stock Titan
Quest Diagnostics (DGX) director boosts holdings with small dividend reinvestment - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP reports small 39-share acquisition - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP adds 37 shares through dividend reinvestment - Stock Titan
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely (NYSE:DGX) - Seeking Alpha
Copeland Capital Management LLC Cuts Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Holdings Decreased by Cwm LLC - MarketBeat
These Companies Are Raising Guidance This Earnings Season - TradingView
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Merck & Company (MRK) - The Globe and Mail
Zurcher Kantonalbank Zurich Cantonalbank Has $14.02 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (NYSE: DGX) boosts Q1 2026 earnings on 11% volume growth - Stock Titan
Quest Diagnostics deal helps push Secaucus office tower past 75% occupancy - Yahoo Finance
Quest Diagnostics Stock Gains 5% After Q1 Earnings Exceed Analyst Expectations - TIKR.com
Quest Diagnostics (NYSE:DGX) Price Target Raised to $229.00 - MarketBeat
Quest Diagnostics (NYSE:DGX) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings - Benzinga
Quest Diagnostics Inc (DGX) 財務データ
収益
当期純利益
現金流量
EPS
0.96%
0.72%
大文字化:
|
ボリューム (24 時間):